We are live on
!
Find out more
PFO
Pathstone Family Office Portfolio holdings
AUM
$13.1B
1-Year Est. Return
21.02%
This Fund
S&P 500
This Quarter
Est. Return
-4.19%
1 Year Est. Return
+21.02%
3 Year Est. Return
+39.27%
5 Year Est. Return
+59.55%
10 Year Est. Return
+237.03%
AUM
$11.1B
AUM Growth
+$6.54B
(+144%)
Cap. Flow
+$7.22B
Cap. Flow
% of AUM
65.14%
Top 10 Holdings %
Top 10 Hldgs %
32.66%
Holding
1,539
New
487
Increased
956
Reduced
24
Closed
69
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$460M |
| 2 |
Microsoft
MSFT
|
+$423M |
| 3 |
Apple
AAPL
|
+$262M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$260M |
| 5 |
Keurig Dr Pepper
KDP
|
+$183M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dimensional US Core Equity Market ETF
DFAU
|
+$56.8M |
| 2 |
iShares Short-Term National Muni Bond ETF
SUB
|
+$28.5M |
| 3 |
Vanguard Morningstar Growth ETF
VUG
|
+$26.9M |
| 4 |
Vanguard Total International Bond ETF
BNDX
|
+$21.7M |
| 5 |
Avantis US Small Cap Value ETF
AVUV
|
+$19.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.62% |
| 2 | Consumer Discretionary | 8.67% |
| 3 | Financials | 6.74% |
| 4 | Consumer Staples | 6.64% |
| 5 | Healthcare | 4.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Regeneron Pharmaceuticals
REGN
$80.8B
| $5.15M | 0.05% |
7,402
+6,249
| +542% | +$3.93M |
|
227
Unilever
UL
$136B
| $5.14M | 0.05% |
104,120
+66,946
| +180% | +$3.5M |
|
228
Waste Management
WM
$91B
| $5.13M | 0.05% |
32,007
+22,924
| +252% | +$3.78M |
|
229
AstraZeneca
AZN
$250B
| $5.12M | 0.05% |
46,516
+33,934
| +270% | +$4.3M |
|
230
Idexx Laboratories
IDXX
$46.2B
| $5.11M | 0.05% |
15,691
+11,794
| +303% | +$4.33M |
|
231
Acumen Pharmaceuticals
ABOS
$176M
| $5.08M | 0.05% |
+506,540
| New | +$2.91M |
|
232
VanEck Gold Miners ETF
GDX
$27.4B
| $5.05M | 0.05% |
209,428
+107,984
| +106% | +$2.73M |
|
233
Ecolab
ECL
$79.9B
| $4.99M | 0.05% |
34,049
+24,185
| +245% | +$3.92M |
|
234
iShares MSCI France ETF
EWQ
$345M
| $4.97M | 0.04% |
185,442
+134,466
| +264% | +$4.04M |
|
235
CME Group
CME
$94.8B
| $4.95M | 0.04% |
27,897
+18,605
| +200% | +$3.68M |
|
236
Colgate-Palmolive
CL
$74.4B
| $4.94M | 0.04% |
69,078
+43,238
| +167% | +$3.39M |
|
237
HDFC Bank
HDB
$121B
| $4.92M | 0.04% |
167,232
+86,310
| +107% | +$2.65M |
|
238
Lam Research
LRCX
$390B
| $4.89M | 0.04% |
128,620
+84,520
| +192% | +$3.76M |
|
|
CHGX
239
DELISTED
AXS Change Finance ESG ETF
CHGX
| $4.88M | 0.04% |
196,720
+87,168
| +80% | +$2.41M |
|
240
Emerson Electric
EMR
$88.3B
| $4.88M | 0.04% |
66,405
+30,909
| +87% | +$2.57M |
|
241
Brown-Forman Class B
BF.B
$13.1B
| $4.84M | 0.04% |
72,558
+38,839
| +115% | +$2.82M |
|
242
Enphase Energy
ENPH
$5.53B
| $4.82M | 0.04% |
17,390
+9,330
| +116% | +$2.52M |
|
243
M&T Bank
MTB
$36.2B
| $4.79M | 0.04% |
27,001
+16,936
| +168% | +$3M |
|
|
PXD
244
DELISTED
Pioneer Natural Resource Co.
PXD
| $4.77M | 0.04% |
22,014
+20,656
| +1,521% | +$4.72M |
|
|
DFS
245
DELISTED
Discover Financial Services
DFS
| $4.74M | 0.04% |
51,750
+40,369
| +355% | +$4.09M |
|
246
ConocoPhillips
COP
$141B
| $4.71M | 0.04% |
45,852
+28,208
| +160% | +$2.81M |
|
247
Zoetis
ZTS
$30B
| $4.66M | 0.04% |
31,306
+25,464
| +436% | +$4.26M |
|
248
iShares Russell Mid-Cap Growth ETF
IWP
$20.7B
| $4.65M | 0.04% |
59,340
+30,640
| +107% | +$2.64M |
|
249
iShares Global REIT ETF
REET
$5.11B
| $4.65M | 0.04% |
218,640
+116,192
| +113% | +$2.86M |
|
250
Devon Energy
DVN
$47.3B
| $4.65M | 0.04% |
77,280
+52,093
| +207% | +$3.24M |
|
Similar funds
CG
API
TA
SCH
PWAG
CS
IWP
MAM
Pathstone Family Office's Q3 2022 Portfolio in Review
As of Q3 2022, Pathstone Family Office held 1,539 positions worth $11.1B, up 144% from $4.54B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Pathstone Family Office deployed $7.22B of net new capital in Q3 2022, opening 487 new positions and adding to 956 existing holdings. Its largest new stake was Keurig Dr Pepper: 4,838,386 shares worth $173M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Dimensional US Core Equity Market ETF, an estimated $56.8M trimmed.
- Pathstone Family Office's largest Q3 2022 buy was Keurig Dr Pepper: 4,838,386 shares worth $173M.
- Pathstone Family Office added most to iShares Core S&P 500 ETF in Q3 2022, an estimated $460M increase.
- Pathstone Family Office's biggest Q3 2022 reduction was Dimensional US Core Equity Market ETF, cutting an estimated $56.8M.
- Pathstone Family Office fully exited Vanguard Total International Bond ETF in Q3 2022, selling an estimated $21.7M.
- Pathstone Family Office's ten largest holdings make up 33% of its $11.1B portfolio in Q3 2022.
- Pathstone Family Office opened 487 new positions and closed 69 in Q3 2022.
- Pathstone Family Office's portfolio value rose 144% quarter-over-quarter to $11.1B.
Based on Pathstone Family Office's 13F filing for Q3 2022, filed 14 Nov 2022.